Post-MI Care, NSTEMI Revascularization, AFIB Anticoagulation, and RSV Outcomes

This week's topics include use of beta blockers after MI, revascularization in NSTEMI, discontinuation of blood thinners after ablation for afib, and use of RSV vaccination and hospitalization and other outcomes.

Program notes:

0:53 Who needs a beta blocker after MI

1:53 Those with mild reduction of ejection fraction

2:53 Confined to those with 40-50% ejection fraction

3:15 Revascularization in NSTEMI

4:20 Composite outcome

5:20 Closes gap, do FFR

6:20 May not be physiologically significant

6:40 Is lifelong anticoagulation needed after ablation

7:41 Occurred less in those who stopped

8:30 RSV, cardiac events and hospitalizations

9:30 Lower hospitalization in those who got the vaccine

10:30 Acute respiratory illness hospitalization

11:30 Less benefit with existing CVD or immunocompromise

12:15 Several RSV vaccines

13:16 End